PM360 2018 Innovative Strategy Patient Recruitment Architecture from Continuum Clinical

Patient Recruitment Architecture

Continuum Clinical

Neil Weisman, President  

It’s common for sponsors to conduct multiple clinical trials with the same compound and to treat each of these trials as a stand-alone project. But Continuum Clinical’s Patient Recruitment Architecture applies traditional consumer brand concepts to clinical trials, allowing sponsors to develop umbrella study collateral that will unlock efficiencies in time and cost while driving long-term value for multiple stakeholders. The architecture reduces or eliminates redundancies often present in patient recruitment plans by establishing common study elements (such as study branding, naming, websites, and the generation of patient and site materials) at the start of the recruitment effort.

The architecture was challenging to put into place because implementation requires some structural shifts within sponsor organizations. Specifically, this architecture relies on getting sponsors to think of studies as programs instead of individual silos—and to fund them at a program level instead of a trial level. By clearly articulating the benefits as they relate to each stakeholder (from patients to HCPs to almost every study team within a sponsor organization), Continuum Clinical has been able to help sponsors see the value of this strategy and adjust their procedures accordingly.

Continuum Clinical first applied its patient recruitment architecture months ago on an oncology program that has since become one of the largest in the history of clinical trials, supporting more than 400 trials in over 30 different tumor types. In total, Continuum Clinical has implemented its patient recruitment architecture for three sponsors to date and so far it has improved the startup phase by an average of three months for each trial following the establishment of the umbrella branding and materials development.


You May Also Like

PM360 2021 Trailblazer Awards Sales Aid Gold Winner Merck and Langland

Taking a patient-centric approach to engaging physicians in squamous cell carcinoma of the head ...

ELITE 2020 Transformational Leader Julie Hurvitz Aliaga of CMI/Compas

Julie Hurvitz Aliaga Senior Vice President, Social Media CMI/Compas Changing the Industry’s Approach to ...

ELITE 2018 PR Guru Christina Zoppi of Novartis Pharmaceuticals Corporation

Christina Zoppi Director, Communications, Neuroscience, U.S. Pharma Novartis Pharmaceuticals Corporation Getting the Word Out ...